.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

LAMISIL Drug Profile

« Back to Dashboard
Lamisil is a drug marketed by Novartis and Glaxosmithkline Cons and is included in eight NDAs. It is available from four suppliers.

The generic ingredient in LAMISIL is terbinafine. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. There is one tentative approval for this compound. Additional details are available on the terbinafine profile page.

Summary for Tradename: LAMISIL

Patents:0
Applicants:2
NDAs:8
Suppliers / Packagers: see list4

Pharmacology for Tradename: LAMISIL

Ingredient-typeAllylamine
Drug ClassAllylamine Antifungal

Clinical Trials for: LAMISIL

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
LAMISIL
terbinafine hydrochloride
TABLET;ORAL020539-001May 10, 1996RXYes<disabled><disabled>
Novartis
LAMISIL
terbinafine hydrochloride
CREAM;TOPICAL020192-001Dec 30, 1992DISCNNo<disabled><disabled>
Novartis
LAMISIL
terbinafine hydrochloride
GRANULE;ORAL022071-001Sep 28, 2007RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LAMISIL

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Cons
LAMISIL
terbinafine hydrochloride
SOLUTION;TOPICAL020749-001Oct 17, 19976,121,314*PED<disabled>
Novartis
LAMISIL
terbinafine hydrochloride
CREAM;TOPICAL020980-001Mar 9, 19994,680,291<disabled>
Novartis
LAMISIL
terbinafine hydrochloride
CREAM;TOPICAL020980-001Mar 9, 19994,755,534*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc